IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3261 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Case Report
   Discussion
   References
   Article Figures

 Article Access Statistics
    Viewed5759    
    Printed97    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
CASE REPORT
Year : 1996  |  Volume : 62  |  Issue : 2  |  Page : 100-102

Bullous pemphigoid in childhood




Correspondence Address:
Rajeev Sharma


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20947993

Rights and PermissionsRights and Permissions

  Abstract 

A young child with clinical presentation and histology like chronic bullous dermatosis of childhood and immunopathology of bullous pemphigoid is being reported to make the readers aware of its existence in Indian population and to stress the importance of immunopathology in bullous disorders of childhood.


Keywords: Childhood bullous pemphigoid, Immunopathology


How to cite this article:
Sharma R, Nadeem M, Chandra M. Bullous pemphigoid in childhood. Indian J Dermatol Venereol Leprol 1996;62:100-2

How to cite this URL:
Sharma R, Nadeem M, Chandra M. Bullous pemphigoid in childhood. Indian J Dermatol Venereol Leprol [serial online] 1996 [cited 2019 Oct 15];62:100-2. Available from: http://www.ijdvl.com/text.asp?1996/62/2/100/4331



  Introduction Top


Bullous pemphigoid (BP) is an autoimmune bullous disorder mostly encountered in the elderly. It is uncommon in children and less than 50 cases have been reported.[1] Clinical presentation of BP is similar in both adults and children but for more frequent involvement of the oral mucous membrane in children.[2] Almost all patients show deposition of IgG and/or C3 at the basement membrane zone (BMZ) on direct immunofluorescence (DIF). Indirect immunofluorescence (IIF) is positive for IgG at BMZ in 70% of adult cases.[3] Clinically it is often confused with chronic bullous dermatosis of childhood and it is very difficult to confirm the diagnosis on histology unless an immunofluorescent or immunohistochemical examination is carried out.


  Case Report Top


A 5-year-old boy was referred for a persistent, severely pruritic, urticarial rash on, the trunk, face, perineal area and proximal limbs associated with occasional blistering. He was not responding to antihistamines and relapsing on withdrawl of steroids. On examination multiple, urticarial plaques were present on the lower back, buttocks, perineal area, groins, thighs, upper arms and trunk [Figure - 1]. Mucosal surfaces were free of lesions and so were the palms and soles. Skin biopsy was taken and submitted to histopathology and immunohistochemical staining. On the third day the child was seen again due to appearance of multiple vesicles, bullae and crusts. Most of them were on urticarial plaques, at places 'string of pearl' appearance was present. The same treatment was continued with a second possibility of bullous pemphigoid. Total and differential leucocyte counts revealed a normal total count with eosinophilia (13%). Haemoglobin estimation, G-6PD estimation, liver and renal function tests were within normal limits. The histology showed a subepidermal bullae with fibrin and a few eosinophils and polymorphs. There was moderate granulocytic infiltrate in the upper dermis with multiple eosinophils [Figure - 2]. Direct immunohistochemical examination of the perilesional skin revealed deposits of IgG at the BMZ in a linear fashion (Avidin-Biotin Complex method) [Figure - 3].

He was weaned off steroids and dapsone 75 mg per day was begun keeping in mind the possibility of chronic bullous dermatosis of childhood due to periorificial localization of the lesions. The lesions resolved with dapsone alone on the 4th day and no new lesions appeared 7th day onwards. The dose was reduced to 50 mg/ day after 2 weeks of remission and the child is now free of lesions except for a short period when dapsone was stopped by his parents for 2 weeks. Further the dose was reduced to 25 mg of dapsone daily for 4 weeks and now he is on 25 mg of dapsone alternate days.


  Discussion Top


It was Lever[4] who first differentiated BP from pemphigus vulgaris on basis of morphology and histopathology. Kim and Winklemann[5] further differentiated BP in childhood from dermatitis herpetiformis of childhood. Before the application of immunopathologic techniques to clinical dermatology earlier cases of childhood BP were probably categorised as dermatitis herpetiformis of childhood.[6] Bean et al[7] described the first case of childhood BP with immunofluorescence findings.

The diagnostic crtieria used to diagnose childhood BP so far in the literature[1] are: (1) patients 18 years of age or younger with the clinical appearance of tense bullae on erythematous or non-erythematous skin with or without mucous membrane involvement, and routine histopathologic study showing subepidermal bulla formation with a variable amount of eosinophis; and more importantly[2] DIF showing linear deposition of IgG and/or C3 as the major immunoreactant(s) at the BMZ and/or a positive IIF showing IgG antibodies reactive with antigen(s) at the BMZ.

The clinical presentation is similar to adults, facial involvement is common in children and can be used as an additional diagnostic clue.[2] Immunopathologic studies of the skin and serum are the most important diagnostic tools to differentiate childhood BP from other acquired immunobullous dermatosis. Direct IF staining of perilesional skin shows linear IgG deposits along BMZ in all patients; complement C3 is found in all skin lesions and at times may be the only immunoreactant present. Other immunoreactants such as IgA, IgM and IgE may also be found rarely. Indirect immunofluorescence testing of the serum shows IgG antibodies to BMZ in 70% patients.[3]

Treatment of choice for BP is prednisone in a dosage of 1-2 mg/day but there are encouraging reports of response to sulfones alone.[8] We gave dapsone considering the relapse on withdrawl of oral steroids. He responded very well and has had no recurrence apart from a short period when the parents stopped dapsone for 2 weeks. The course of childhood BP is protracted but self limited. With therapy childhood BP usually follows a benign course. The majority of cases enter remission within 1 year. Overall childhood BP has an excellent prognosis.

 
  References Top

1.Nemeth AJ, Klein AD, Gould EW, Schachner LA. Childhood bullous pemphigoid. Arch Dermatol 1991;127:378-86.  Back to cited text no. 1  [PUBMED]  
2.Venning VA, Frith PA, Bron J, et al. Mucosal involvement in bullous and cicatricial pemphigoid: a clinical and immunopathological study. Br J Dermatol 1988;118:7-15.  Back to cited text no. 2    
3.Thivolet J, Barthelemy H. Bullous pemphigoid. Sem Dermatol 1988; 7:91-102.  Back to cited text no. 3  [PUBMED]  
4.Lever WF. Pemphigus. Medicine 1953;32:1-123.  Back to cited text no. 4  [PUBMED]  
5.Kim R, Winklemann R. Dermatitis herpetiformis in children: relationship to bullous pemphigoid. Arch Dermatol 1961;83:895-902.  Back to cited text no. 5    
6.Jablonska S, Chorzelski T, Beutner EH, Blaszezyk M. Juvenile dermatitis herpetiformis in the light of immunofluorescence studies. Br J Dermatol 1971;85:307-13.  Back to cited text no. 6    
7.Bean SF, Gord RA, Windhorst DB. Bullous pemphigoid in an 11-year-old boy. Arch Dermatol 1971;103:88-90.  Back to cited text no. 7    
8.Venning VA, Millard PR, Wojnasowska. Dapsone as first line therapy for bullous pemphigoid. Br J Dermatol 1989;120:83-92.  Back to cited text no. 8    


    Figures

[Figure - 1], [Figure - 2], [Figure - 3]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow